Chemical Peels and Fractional Laser on IGF-1 Levels in Skin
Massachusetts General Hospital · NCT03775031
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 55+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 20
- US sites recruiting
- 1
- Study start
- December 1, 2019
- Record last updated
- October 22, 2020
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to evaluate the impact of fractional laser versus chemical peels on IGF-1 levels in skin.
Being studied: Fractional Laser and Chemical Peel
Conditions: Skin Cancer
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Male and female subjects >55 years old
- Fitzpatrick type I-II
- Able to provide informed consent.
- Cutaneous photodamage of 3 or above on the Larnier photodamage scale (see Appendix).
Exclusion Criteria
- Prior laser or peel treatment in the area evaluated in the current study in the past year.
- Currently taking immunosuppressant medications known to interfere wound healing or anti-inflammatory medications (such as NSAIDs, or steroids).
- Subjects who have underlying diseases that could alter wound healing response (such as Diabetes).
- Currently taking insulin.
- History of substance abuse, mental dysfunction, or other factors limiting ability to cooperate with study.
- History of abnormal scarring such as Keloids.
- History of vitiligo.
- Allergy or sensitivity or allergy to topical anesthesia
- Inability to use sunscreen.
- History of smoking in the last 10 years
- Scar or prior surgery in the area of treatment.
- Use of isotretinoin in the prior 6 months
- Subjects who have bleeding disorders or who are taking anticoagulants
Recruiting US locations
Massachusetts General Hospital Clinical Unit for Research Trials and Outcomes in Skin
Boston, MA 02114
Site contact: Molly Wanner · 617-726-5066 · harvardskinstudies@partners.org
Study contacts (from the official record)
- Molly Wanner, MD · 617-726-5066 · mwanner@mgh.harvard.edu
Similar studies in Massachusetts
All healthy volunteers studies in Massachusetts →- RecruitingHealthy volunteersPhase 1/Phase 2
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
Atavistik Bio, Inc
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
Haya Therapeutics, Inc.
- Location
- Boston, MA + 2 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55